Dr. Cmelak Discusses the Results of the ECOG1308 Study

Anthony J. Cmelak, MD
Published: Thursday, Jul 24, 2014

Anthony J. Cmelak, MD, professor, Radiation Oncology, Vanderbilt-Ingram Cancer Center, discusses the results of ECOG1308, a study that evaluated reduced-dose IMRT in HPV-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response to induction chemotherapy.

Cmelak says previous data showed that these patients had very good outlook and overall survival with standard chemotherapy. In this large phase II study, researchers attempted to minimize toxicity by using upfront chemotherapy for three cycles. Patients that had a complete clinical response went on to IMRT, Cmelak says.

The goal of the study was to minimize long-term toxicities associated with radiation.

The study found that patients with less aggressive, HPV-associated OPSCC can be effectively treated with a lower-dose radiation regimen depending upon their response to combination induction therapy.

Anthony J. Cmelak, MD, professor, Radiation Oncology, Vanderbilt-Ingram Cancer Center, discusses the results of ECOG1308, a study that evaluated reduced-dose IMRT in HPV-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response to induction chemotherapy.

Cmelak says previous data showed that these patients had very good outlook and overall survival with standard chemotherapy. In this large phase II study, researchers attempted to minimize toxicity by using upfront chemotherapy for three cycles. Patients that had a complete clinical response went on to IMRT, Cmelak says.

The goal of the study was to minimize long-term toxicities associated with radiation.

The study found that patients with less aggressive, HPV-associated OPSCC can be effectively treated with a lower-dose radiation regimen depending upon their response to combination induction therapy.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x